Equities

Medtech Acquisition Corp

MTAC:NAQ

Medtech Acquisition Corp

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)10.04
  • Today's Change-0.01 / -0.10%
  • Shares traded2.18k
  • 1 Year change+0.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2022 14:46 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

MedTech Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses primarily operating in the healthcare sector in the United States. The Company has not commenced any business operations and has not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD8.78m
  • Incorporated2020
  • Employees--
  • Location
    Medtech Acquisition Corp48 Maple Avenue, 22nd FloorGREENWICH 06830United StatesUSA
  • Phone+1 (908) 391-1288
  • Fax+1 (302) 636-5454
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MTAC:NAQ since
announced
Transaction
value
TriSalus Life Sciences IncAnnounced14 Nov 202214 Nov 2022Announced0.20%220.00m
Data delayed at least 15 minutes, as of Nov 25 2022 14:46 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Stratim Cloud Acquisition Corp0.007.21m310.94m2.0043.091.29145.78--0.23090.23090.007.710.00----0.002.87--2.87--------------0.00------963,714.00------
SilverSPAC Inc0.006.65m311.25m--47.181.3043.46--0.21110.21110.007.670.00------2.64--2.65--------------0.00--------------
Jaguar Global Growth Corporation I0.005.21m311.27m--72.151.36----0.14070.14070.007.440.00------4.37--4.38--------------0.00--------------
Source Capital, Inc.11.96m-32.06m312.00m0.00--0.9307--26.08-3.84-3.841.4340.180.0319--5.27---8.548.01-8.628.1275.2768.75-268.02316.22--0.20930.0074.9525.1610.9195.998.28--4.99
Hudson Executive Investment Corp II0.0010.14m312.19m0.0027.910.259130.79--0.3580.3580.0038.550.00------4.03--4.05--------------0.00------323,485.00------
Monument Circle Acquisition Corp0.009.90m312.81m0.0031.591.30----0.31690.31690.007.700.00------3.94--3.95--------------0.0013------198,681.80------
Medtech Acquisition Corp0.008.78m313.75m--35.741.3153.34--0.28090.28090.007.650.00------3.50--3.51--------------0.0029------770.14------
Live Oak Mobility Acquisition Corp0.0010.56m314.67m--29.561.29----0.33660.33660.007.690.00------4.14--4.15--------------0.00--------------
Clean Earth Acquisitions Corp-100.00bn-100.00bn314.94m----1.41----------7.10----------------------------0.00--------------
New Providence Acquisition Corp II0.00-163.56k315.00m0.00--1.27-----0.0052-0.00520.007.910.00-------0.1268---0.1278--------------0.00--------------
WhiteHorse Finance Inc80.05m20.04m315.41m--15.650.9195--3.940.8670.8673.4714.760.1049--8.53--2.636.152.716.3648.6948.8325.0457.80--2.470.556884.1116.936.02-5.02-0.8011--0.00
Invesco Municipal Income Opp Trust20.70m-48.38m316.10m----1.01--15.27-1.02-1.020.43496.580.0453--5.57---10.583.95-10.823.9880.3379.53-233.7080.82--0.25570.2368100.02-4.67-1.7592.82-10.15---1.41
Putnam Managed Municipal Income Trust18.69m-46.76m316.55m----0.9312--16.93-0.9591-0.95910.38249.010.0355-------8.843.72-9.063.7881.7683.52-249.0289.82--0.24210.101994.01-4.73-6.76416.381.39---2.69
Rosecliff Acquisition Corp I0.005.00m316.72m--63.291.31----0.15820.15820.007.650.00------1.97--1.98--------------0.00-------315,823.50------
Banyan Acquisition Corp0.0013.17m316.78m--20.951.34----0.48170.48170.007.550.00------10.55--10.60--------------0.00--------------
Data as of Nov 25 2022. Currency figures normalised to Medtech Acquisition Corp's reporting currency: US Dollar USD

Institutional shareholders

38.51%Per cent of shares held by top holders
HolderShares% Held
BlackRock Advisors LLCas of 30 Sep 20221.79m7.17%
Magnetar Financial LLCas of 30 Sep 20221.28m5.12%
Deerfield Management Co. LPas of 30 Sep 20221.00m4.00%
Glazer Capital LLCas of 30 Sep 2022963.03k3.85%
BlackRock Investment Management (UK) Ltd.as of 30 Sep 2022876.48k3.51%
Marshall Wace LLPas of 30 Sep 2022795.52k3.18%
BMO Asset Management Corp.as of 30 Sep 2022777.02k3.11%
HSBC Global Asset Management (UK) Ltd.as of 30 Sep 2022730.32k2.92%
First Trust Capital Management LPas of 30 Sep 2022713.53k2.85%
Bank of America, NA (Private Banking)as of 30 Sep 2022700.00k2.80%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.